Page - 47 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Dawidczyket al. Nanomedicines for cancer therapy Sumitani, S., Oishi,M., andNagasaki, Y. (2011). Carborane confined nanoparti- cles for boron neutron capture therapy: improved stability, blood circulation time and tumor accumulation. React. Funct. Polym. 71, 684–693. doi: 10.1016/j.reactfunctpolym.2011.03.010 Sun,X.L.,Huang,X.L.,Guo, J.X.,Zhu,W.L.,Ding,Y.,Niu,G.,etal. (2014).Self- illuminatingCu-64-DopedCdSe/ZnSnanocrystals for in vivo tumor Imaging. J.Am.Chem.Soc.136,1706–1709.doi:10.1021/ja410438n Tang,L.,Yang,X. J.,Dobrucki,L.W.,Chaudhury, I.,Yin,Q.,Yao,C., et al. (2012). Aptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymphnodeswithmetastatic tumors.Angew. Chem. Int.Ed.Engl.51,12721–12726.doi:10.1002/anie.201205271 Tinkov, S.,Winter,G.,Coester,C., andBekeredjian,R. (2010).Newdoxorubicin- loaded phospholipid microbubbles for targeted tumor therapy: part I— Formulationdevelopmentand in-vitrocharacterization. J.Control.Release143, 143–150.doi:10.1016/j.jconrel.2009.12.026 Torchilin, V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Deliv. Rev. 63, 131–135. doi: 10.1016/j.addr.2010. 03.011 Tuerk, C., and Gold, L. (1990). Systematic evolution of ligands by exponential enrichment—RNA ligands to bacteriophage-t4DNA-polymerase. Science 249, 505–510.doi:10.1126/science.2200121 Turk,M. J.,Waters,D. J., andLow,P. S. (2004).Folate-conjugated liposomespref- erentially targetmacrophages associatedwith ovarian carcinoma.Cancer Lett. 213,165–172.doi:10.1016/j.canlet.2003.12.028 Ujiie,K.,Kanayama,N.,Asai,K.,Kishimoto,M.,Ohara,Y.,Akashi,Y.,etal. (2011). Preparationofhighlydispersibleandtumor-accumulative, ironoxidenanopar- ticles Multi-point anchoring of PEG-b-poly(4-vinylbenzylphosphonate) improves performance significantly.Colloids Surf. BBiointerfaces 88, 771–778. doi:10.1016/j.colsurfb.2011.08.013 Vanblaaderen, A., andVrij, A. (1992). Synthesis and characterization of colloidal dispersionsoffluorescent,monodispersesilicaspheres.Langmuir8,2921–2931. doi:10.1021/la00048a013 Verma, S.,Miles,D.,Gianni, L., Krop, I. E.,Welslau,M., Baselga, J., et al. (2012). Trastuzumab emtansine forHER2-positive advanced breast cancer.N.Engl. J. Med.367,1783–1791.doi:10.1056/NEJMoa1209124 Vllasaliu,D., Fowler, R., andStolnik, S. (2014). PEGylatednanomedicines: recent progress and remaining concerns. Expert Opin. DrugDeliv. 11, 139–154. doi: 10.1517/17425247.2014.866651 VonMaltzahn, G., Park, J. H., Agrawal, A., Bandaru, N. K., Das, S. K., Sailor, M. J., et al. (2009). Computationally guided photothermal tumor therapy using long-circulatinggoldnanorodantennas.CancerRes.69, 3892–3900.doi: 10.1158/0008-5472.CAN-08-4242 Walkey,C.D.,andChan,W.C.W.(2012).Understandingandcontrollingtheinter- action of nanomaterials with proteins in a physiological environment.Chem. Soc.Rev.41,2780–2799.doi:10.1039/c1cs15233e Wang, H. E., Yu, H. M., Lu, Y. C., Heish, N. N., Tseng, Y. L., Huang, K. L., et al. (2006). Internal radiotherapy and dosimetric study for In-111/Lu-177- pegylated liposomesconjugates in tumor-bearingmice.Nucl. Instrum.Methods Phys.Res.Sec.A.569,533–537.doi:10.1016/j.nima.2006.08.124 Wang,M., andGartel,A.L. (2011).Micelle-encapsulated thiostreptonasaneffec- tive nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts.Mol. Cancer Ther. 10, 2287–2297. doi: 10.1158/1535- 7163.MCT-11-0536 Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T., and Josephson, L. (2005). Cell-specific targeting of nanoparticles by multivalent attachment of small molecules.Nat.Biotechnol.23,1418–1423.doi:10.1038/nbt1159 Xiao, Y. L., Hong, H., Javadi, A., Engle, J. W., Xu, W. J., Yang, Y. A., et al. (2012).Multifunctional unimolecularmicelles for cancer-targeted drug deliv- ery and positron emission tomography imaging.Biomaterials 33, 3071–3082. doi:10.1016/j.biomaterials.2011.12.030 Yang, K., Hu, L. L., Ma, X. X., Ye, S. Q., Cheng, L., Shi, X. Z., et al. (2012).Multimodal imagingguidedphotothermaltherapyusingfunctionalized graphene nanosheets anchored withmagnetic nanoparticles.Adv. Mater. 24, 1868–1872.doi:10.1002/adma.201104964 Yang, X., Hong, H., Grailer, J. J., Rowland, I. J., Javadi, A., Hurley, S. A., et al. (2011). cRGD-functionalized, DOX-conjugated, and (6)(4)Cu- labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 32, 4151–4160. doi: 10.1016/j.biomaterials.2011.02.006 Yardley,D.A. (2013).nab-Paclitaxelmechanismsofactionanddelivery. J.Control. Release170,365–372.doi:10.1016/j.jconrel.2013.05.041 Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K., and Kataoka, K. (1999). Selective delivery of adiramycin to a solid tumor using a polymeric micelle carrier system. J. Drug Target. 7, 171–186. doi: 10.3109/10611869909085500 Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C.M., Sievers, E. L., et al. (2010). Brentuximab vedotin (SGN-35) for relapsed CD30- positive lymphomas.N. Engl. J. Med. 363, 1812–1821. doi: 10.1056/NEJMoa 1002965 Yu, B., Mao, Y., Bai, L. Y., Herman, S. E., Wang, X., Ramanunni, A., et al. (2013). Targeted nanoparticle delivery overcomes off-target immunostimula- tory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia. Blood 121, 136–147. doi: 10.1182/blood-2012-01- 407742 Zhan, C., Gu, B., Xie, C., Li, J., Liu, Y., and Lu, W. (2010). Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J. Control. Release 143, 136–142. doi: 10.1016/j.jconrel.2009.12.020 Zhang,R.,Lu,W.,Wen,X.,Huang,M.,Zhou,M.,Liang,D.,etal. (2011a).Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis. J.Nucl.Med.52,958–964.doi:10.2967/jnumed.110.083220 Zhang, R., Xiong, C., Huang,M., Zhou,M.,Huang,Q.,Wen, X., et al. (2011b). Peptide-conjugatedpolymericmicellarnanoparticles forDualSPECTandopti- cal imagingof EphB4 receptors in prostate cancer xenografts.Biomaterials 32, 5872–5879.doi:10.1016/j.biomaterials.2011.04.070 Zhang, Y., Satterlee, A., andHuang, L. (2012). In vivo gene delivery by nonviral vectors:overcominghurdles?Mol.Ther.20,1298–1304.doi:10.1038/mt.2012.79 Zhao, J., Song, S. L., Zhong,M., and Li, C. (2012). Dual-modal tumor imaging via long-circulating biodegradable core-cross-linked polymeric micelles.ACS MacroLett.1,150–153.doi:10.1021/mz200034f Zheng, J., Jaffray,D., andAllien,C. (2009).QuantitativeCT imagingof the spatial and temporal distributionof liposomes in a rabbit tumormodel.Mol. Pharm. 6,571–580.doi:10.1021/mp800234r Zhu,H.,Zhao, J.,Lin,X.F.,Hong,Y.,Li,C., andYang,Z. (2013).Design, synthesis and evaluation of dual-modality glyco-nanoparticles for tumor imaging. Molecules18,6425–6438.doi:10.3390/molecules18066425 Conflict of Interest Statement:The authors declare that the research was con- ducted in the absence of any commercial or financial relationships that could be construedasapotential conflictof interest. Received: 20 June 2014; paper pending published: 03 July 2014; accepted: 05August 2014;publishedonline:25August2014. Citation:DawidczykCM,RussellLMandSearsonPC(2014)Nanomedicines forcan- cer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments.Front.Chem.2:69.doi: 10.3389/fchem.2014.00069 Thisarticlewas submitted toChemicalEngineering,a sectionof the journalFrontiers inChemistry. Copyright © 2014 Dawidczyk, Russell and Searson. This is an open-access article distributed under the terms of the Creative CommonsAttribution License (CCBY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, inaccordancewithacceptedacademicpractice.Nouse,distributionor reproduction ispermittedwhichdoesnot complywith these terms. www.frontiersin.org August2014 |Volume2 |Article69 | 47